
Join IPA at BIO San Diego June 13-16
• Booth #4017
Don't miss the opportunity to schedule a meeting to learn more about the Talem vault of next-gen, fully human programs and our new LENSai Complex Intelligence Technology.
GOIPA Completes Acquisition of BioStrand BV… Learn More.
• Booth #4017
Don't miss the opportunity to schedule a meeting to learn more about the Talem vault of next-gen, fully human programs and our new LENSai Complex Intelligence Technology.
GOThis changes everything.
PRESS RELEASE: See how the acquisition of Biostrand complements IPA and its goal to change the paradigm for solving therapeutic needs like PERSONALIZED MEDICINE ― with a radically new approach to harnessing complex biological intelligence …
GOFor this and additional recent IPA announcements including IPA Selected to Partner with Elektrifi…for Future Pandemic Prep for Agencies of the US Department of Defense (D.O.D.)…
GOEngineered for the scientific race.
Our SCIENTIFIC INTELLIGENCE and research teams provide full-scale antibody discovery and development services driven by relentlessly robust outcomes, diverse candidate pools and a wide range of platforms and technologies.
Engineered for the clinical race.
Our clinical BUSINESS intelligence arm takes the CRO to the next level by matching high value targets to fully vetted, premium antibody programs.
A new lens on biotherapeutic intelligence:
HYFT Multi-Omics technology elevates all research activities at IPA with a new paradigm for solving therapeutic needs like PERSONALIZED MEDICINE, With it, we bring the biosphere into focus and turn infinite biological data into meaningful knowledge.
The LENSai platform provides exclusive access to untapped, original PRECISION medicine solutions― with more accuracy than ever before.